Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.310 -0.010 (-0.76%)

Streaming Delayed Price Updated: 12:41 PM EDT, Sep 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	857,897
Open	1.340
Bid (Size)	1.300 (16,300)
Ask (Size)	1.310 (2,100)
Prev. Close	1.320
Today's Range	1.300 - 1.340
52wk Range	0.5632 - 2.979
Shares Outstanding	210,356,896
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP ↗

Today 7:02 EDT

Inovio Pharmaceuticals (NASDAQ:INO) is approaching an October 30 PDUFA date for INO-3107, its lead DNA medicine candidate for recurrent respiratory papillomatosis, or RRP, President and CEO Jacky Shea...

Via MarketBeat

Inovio (INO) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

INO-3107 advances toward October FDA decision as company extends cash runway through early 2027.

Via The Motley Fool

Performance

YTD	-22.5%	-22.5%
1 Month	+77.9%	+77.9%
3 Month	+20.2%	+20.2%
6 Month	-22.5%	-22.5%
1 Year	-52.4%	-52.4%

More News

Inovio Pharmaceuticals Q2 Earnings Call Highlights ↗

August 12, 2026

Via MarketBeat

Here are the top movers in Thursday's session. ↗

July 30, 2026

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 30, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

July 30, 2026

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

July 29, 2026

Via Chartmill

Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances ↗

May 25, 2026

Via MarketBeat

Inovio (INO) Q1 2026 Earnings Call Transcript ↗

May 13, 2026

Via The Motley Fool

Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? ↗

May 11, 2026

Via The Motley Fool

Get insights into the top gainers and losers of Friday's after-hours session. ↗

May 08, 2026

Via Chartmill

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

April 07, 2026

From Pomerantz LLP

Via GlobeNewswire

Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

April 07, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026

April 07, 2026

From Faruqi & Faruqi, LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th

April 06, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

On Monday, there are stocks with unusual volume. Let's take a look. ↗

April 06, 2026

Via Chartmill

Deadline Soon: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

April 06, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 06, 2026

From Schall Law

Via GlobeNewswire

Here are the top movers in Thursday's session. ↗

April 02, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-04-02: top gainers and losers in today's session. ↗

April 02, 2026

Via Chartmill

What's Behind The Drop In Inovio Pharmaceuticals Stock Today? ↗

April 02, 2026

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

April 02, 2026

Via Chartmill

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

April 02, 2026

From Schall Law

Via GlobeNewswire

INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026

April 02, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Discover the top movers in Thursday's pre-market session. ↗

April 02, 2026

Via Chartmill

Frequently Asked Questions

Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?

Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market

What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?

The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.310

When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 09/10/26 12:41 PM ET

What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 275.57M

How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?

Inovio Pharmaceuticals, Inc. - Common Stock has 276M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.